These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17950067)

  • 1. Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.
    Kollins SH; March JS
    Biol Psychiatry; 2007 Nov; 62(9):951-3. PubMed ID: 17950067
    [No Abstract]   [Full Text] [Related]  

  • 2. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
    DelBello MP
    J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
    [No Abstract]   [Full Text] [Related]  

  • 3. Attention-Deficit Hyperactivity Disorder.
    DuPont RL
    Essent Psychopharmacol; 2005; 6(5):iv. PubMed ID: 16222908
    [No Abstract]   [Full Text] [Related]  

  • 4. New approaches to the management and treatment of attention-deficit/hyperactivity disorder.
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S87-8. PubMed ID: 15352534
    [No Abstract]   [Full Text] [Related]  

  • 5. Attention-deficit hyperactivity disorder. The psychostimulants and beyond.
    Ludwikowski K; DeValk M
    Adv Nurse Pract; 1998 Feb; 6(2):55-6, 59-60. PubMed ID: 9555283
    [No Abstract]   [Full Text] [Related]  

  • 6. Attention-deficit/hyperactivity disorder psychopharmacology for college students.
    Staufer WB; Greydanus DE
    Pediatr Clin North Am; 2005 Feb; 52(1):71-84, viii. PubMed ID: 15748925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention deficit hyperactivity disorder in prison.
    Ghanizadeh A; Akhondzadeh S
    J Am Acad Psychiatry Law; 2009; 37(2):278. PubMed ID: 19535565
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of action of stimulants in attention-deficit/hyperactivity disorder.
    Stahl SM
    J Clin Psychiatry; 2010 Jan; 71(1):12-3. PubMed ID: 20129003
    [No Abstract]   [Full Text] [Related]  

  • 9. [The decision to give central nervous system stimulants to a child (proceedings)].
    Thivierge J
    Ann Med Psychol (Paris); 1979; 137(3-4):251-2. PubMed ID: 40512
    [No Abstract]   [Full Text] [Related]  

  • 10. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 11. Medications for attention deficit hyperactivity disorder: cardiovascular concerns.
    Wooltorton E
    CMAJ; 2006 Jul; 175(1):29. PubMed ID: 16772535
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment with central nervous system stimulants].
    Zlotnik G
    Ugeskr Laeger; 2004 Mar; 166(10):925; author reply 925. PubMed ID: 15045741
    [No Abstract]   [Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder: focus on pharmacologic management.
    Reitz SJ
    J Pediatr Health Care; 1997; 11(2):78-83. PubMed ID: 9155352
    [No Abstract]   [Full Text] [Related]  

  • 15. Attention-deficit hyperactivity disorder and anesthesia.
    Forsyth I; Bergesio R; Chambers NA
    Paediatr Anaesth; 2006 Apr; 16(4):371-3. PubMed ID: 16618289
    [No Abstract]   [Full Text] [Related]  

  • 16. [Central nervous system stimulants to hyperactive children? Time to soften up the attitude towards an efficient treatment].
    Gillberg C
    Lakartidningen; 1997 Jun; 94(23):2161-2. PubMed ID: 9213677
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].
    Rollini M; Baud P
    Rev Med Suisse; 2008 Jul; 4(165):1638-43. PubMed ID: 18767289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence and belief in attention deficit hyperactivity disorder. Narrow focus of editorial was disappointing.
    Timimi S
    BMJ; 2001 Mar; 322(7285):555-6. PubMed ID: 11263457
    [No Abstract]   [Full Text] [Related]  

  • 19. Medication for attention deficit hyperactivity disorder: commentary and response.
    Faigel HC; Heiligenstein E
    J Am Coll Health; 1996 Jul; 45(1):40-1; discussion 41-2. PubMed ID: 8708265
    [No Abstract]   [Full Text] [Related]  

  • 20. Common comorbidities seen in adolescents with attention-deficit/hyperactivity disorder.
    Young J
    Adolesc Med State Art Rev; 2008 Aug; 19(2):216-28, vii. PubMed ID: 18822828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.